Riskpilot← Back to searchSign inGet full accessSØGNE FOTTERAPI AS
ASActiveOrg 925125733Rådhusveien 30B, 4640 SøgneRental and operating of own or leased real estate · NACE 6820Est. 20203 employees
Revenue 2024
NOK 2,1M
+18% vs 2023
EBITDA margin
15.3%
+244% vs 2023
Equity ratio
5.0%
Financial strength
Net profit 2024
NOK 204K
+183% vs 2023
| Revenue | NOK 2,1M | +18% |
| EBITDA | NOK 322K | +244% |
| Net profit | NOK 204K | +183% |
| Total assets | NOK 4,3M | +877% |
| Equity | NOK 215K | +1861% |
| Employees | 3 | — |
Legal name
SØGNE FOTTERAPI AS
Org number
925125733
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
27. mai 2020
Share capital
NOK 30 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller daglig leder alene.
Company purpose
Fotbehandling, produksjon og tilpassing av sko for salg, samt salg av produkter og annet som faller naturlig inn under dette. Samt investering i andre selskaper og kjøp, salg og utvikling av fast eiendom.
Address
Rådhusveien 30B, 4640 Søgne
Email
post@sognefotterapi.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 263 | 1 985 | 2 053 | 1 790 | 2 107 |
| Staff expenses | −423 | −1 157 | −1 243 | −1 275 | −894 |
| EBITDA | 175 | 79 | 51 | −225 | 322 |
| Depreciation & amort. | −9 | −20 | −20 | −23 | −105 |
| EBIT | 167 | 60 | 32 | −248 | 217 |
| Net financials | 3 | −2 | 17 | −2 | −14 |
| Profit before tax | 170 | 57 | 48 | −250 | 204 |
| Tax | 37 | 13 | −0 | −5 | −0 |
| Net profit | 133 | 44 | 48 | −245 | 204 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 349 | 567 | 632 | 438 | 4 276 |
| Equity | 158 | 202 | 256 | 11 | 215 |
| Long-term debt | 4 | 5 | 5 | 0 | 3 735 |
| Short-term debt | 187 | 360 | 372 | 427 | 327 |
| Total debt | 191 | 365 | 376 | 427 | 4 062 |
EBITDA margin
15.3%
This company
15.8%
Market median
+3% vs market
20202024
Equity ratio
5.0%
This company
38.2%
Market median
-87% vs market
20202024
Return on equity
94.9%
This company
18.4%
Market median
+416% vs market
20202024
Net profit margin
9.7%
This company
8.1%
Market median
+20% vs market
20202024
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20202024
Debt / equity
18.93×
This company
0.62×
Market median
-2953% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AG Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
AT Chief Executive Officer | Chief Executive Officer | 2020 – 2023 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SØGNE FOTTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anette Trydal | Chief Executive Officer | 0 companies |
| Anette Grindland | Chief Executive Officer | 0 companies |